Today's Hours: Closed
Lane Medical Library

Search

Filter Results

Did You Mean:

Search Results

Sort by
relevance
  • Book
    Jennifer Steel, editor.
    Summary: The inadequate supply of organs in the United States and other countries continues to drive the reliance on living donor transplantation. Representatives of the transplant community convened for a meeting on living donation in an effort to provide guidelines to promote the welfare of living donors. The consensus statement that resulted from this meeting recommended that transplant centers retain an Independent Living Donor Advocate (ILDA) to focus on the best interest of the donor. Over a decade later, nearly every transplant center in the United States, performing living donor surgeries, has incorporated an ILDA into their living donor screening and/or evaluation process, however there are no guidelines with regard to the ILDA's qualifications, clinical practice, or how address ethical challenges.

    Contents:
    Part I: Living Donation: Chapter 1: The Medical Selection of Live Donors,- Chapter 2: Kidney Paired Donation Programs for Incompatible Living Kidney Donors and Recipients
    Chapter 3: Living Donor Liver Transplantation
    Chapter 4: Intestinal Transplantation from Living Donors
    Chapter 5: Living Donor Lung Transplantation
    Chapter 6: Live Donor Pancreas Transplantation
    Part II: Living Donor Advocacy: Chapter 7: The History of Living Donor Advocacy in Living Donor Transplantation
    Chapter 8: Findings from a National Survey of Living Donor Advocates
    Chapter 9: The Independent Donor Advocate and the Independent Donor Advocate Team
    Chapter 10: Clasification of Living Organ Donors
    Chapter 11: Unrelated Donors
    Chapter 12: Education of the Donor by the ILDA (Psychosocial Aspects)
    Chapter 13: Components and Timing of the ILDA Evaluation
    Chapter 14: Contraindications to Living Donation from an ILDA Perspective
    Chapter 15: Management of Conflict Between the Independent Living Donor Advocate and the Transplant Team
    Chapter 16: Story Behind the Story
    Chapter 17: Living Donor Experience
    Part III: Living Donor Ethics: Chapter 18: Informed Consent for Living Organ Donation
    Chapter 19: Pressure and Coercion
    Chapter 20: Financial Considerations
    Chapter 21: Autonomy, Agency, and Responsibility: Ethical Concerns for Living Donor Advocates
    Chapter 22: A Practical Guide: Role of the Independent Living Donor Advocate: Protect or Advocate or Is It Both/And?
    Chapter 23: Racial Disparities in Kidney Transplant and Living Donation
    Chapter 24: The Evolution of the Role of the Independent Living Donor Advocates: Recommendations for Practice Guidelines.
    Digital Access Springer 2014
  • Article
    Rosenhall U, Nyman H, Stahle J.
    ORL J Otorhinolaryngol Relat Spec. 1977;39(5):285-91.
    The vestibular sensory epithelia from 3 patients treated with cytotoxic drugs were studied with a surface specimen technique, 2 cases had been treated with cyclophosphamide and 1 with melphalan. In all 3 cases there was some slight degeneration affecting the cristae ampullares. The macula utriculi showed no signs of degeneration. The degeneration affecting the cristae is probably too slight to produce any serious symptoms from the vestibular apparatus.
    Digital Access Access Options